DexCom (DXCM) Stock Price Today & Analysis
DXCM
Valuation
Market cap$27.12B
Price-to-sales ratio5.98
Price-to-book value9.91
Price-earnings ratio37.50
Return on Equity30.00%
Return on Sales0.22%
Return on Assets0.10%
PEG ratioN/A
Earnings Per Share
Earnings Per Share$1.84
Income Statement
Average volume4,820,118
EBITDA$1.22B
1 year high (52w)$93.25
1 year low (52w)$54.11
Dividend
Dividend yield0.00%
Solvency
Debt-to-equity ratioN/A
About DexCom
Dexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world.
FAQ
You can easily purchase DexCom (DXCM) shares through the Gotrade app. Simply download the app, set up your account, fund it, and then search for the 'DXCM' ticker to begin your investment journey.
At Gotrade, you can kickstart your investment in DexCom with as little as $1.
Absolutely. Brokerage services on Gotrade Indonesia are provided by PT Valbury Asia Futures, a licensed futures and commodities broker registered with and supervised by the Indonesian Financial Services Authority (OJK).
Yes. Gotrade provides access to U.S. stocks from Indonesia through fully backed shares. This is facilitated through a cross-border order routing scheme for foreign stock derivative contracts (PALN), in accordance with regulations from Bappebti (the Commodity Futures Trading Regulatory Agency).
When you trade, you enter into a contract with PT Valbury Asia Futures (Valbury), a Bappebti-registered broker in Indonesia. Valbury, in turn, fully backs its contracts 1-for-1 with Alpaca Securities LLC, a FINRA-licensed broker-dealer in the United States. For every share (or fraction thereof) you hold on Gotrade, a corresponding share is held by Valbury in a separate, segregated brokerage account at Alpaca Securities LLC.
